143 related articles for article (PubMed ID: 2554438)
1. Internalization of glucagon-like peptide-1(7-36)amide in rat insulinoma cells.
Göke R; Richter G; Göke B; Trautmann M; Arnold R
Res Exp Med (Berl); 1989; 189(4):257-64. PubMed ID: 2554438
[TBL] [Abstract][Full Text] [Related]
2. Receptors for glucagon-like peptide-1(7-36) amide on rat insulinoma-derived cells.
Göke R; Conlon JM
J Endocrinol; 1988 Mar; 116(3):357-62. PubMed ID: 2832504
[TBL] [Abstract][Full Text] [Related]
3. Solubilization of active GLP-1 (7-36)amide receptors from RINm5F plasma membranes.
Göke R; Oltmer B; Sheikh SP; Göke B
FEBS Lett; 1992 Apr; 300(3):232-6. PubMed ID: 1313374
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1(7-36)amide: characterization of the domain responsible for binding to its receptor on rat insulinoma RINm5F cells.
Gallwitz B; Schmidt WE; Conlon JM; Creutzfeldt W
J Mol Endocrinol; 1990 Aug; 5(1):33-9. PubMed ID: 2168708
[TBL] [Abstract][Full Text] [Related]
5. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.
Göke R; Fehmann HC; Linn T; Schmidt H; Krause M; Eng J; Göke B
J Biol Chem; 1993 Sep; 268(26):19650-5. PubMed ID: 8396143
[TBL] [Abstract][Full Text] [Related]
6. Detection of the human glucagon-like peptide 1(7-36) amide receptor on insulinoma-derived cell membranes.
Lankat-Buttgereit B; Göke R; Stöckmann F; Jiang J; Fehmann HC; Göke B
Digestion; 1994; 55(1):29-33. PubMed ID: 8112494
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
[TBL] [Abstract][Full Text] [Related]
8. Signal transmission after GLP-1(7-36)amide binding in RINm5F cells.
Göke R; Trautmann ME; Haus E; Richter G; Fehmann HC; Arnold R; Göke B
Am J Physiol; 1989 Sep; 257(3 Pt 1):G397-401. PubMed ID: 2551182
[TBL] [Abstract][Full Text] [Related]
9. Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental results.
Gotthardt M; Fischer M; Naeher I; Holz JB; Jungclas H; Fritsch HW; Béhé M; Göke B; Joseph K; Behr TM
Eur J Nucl Med Mol Imaging; 2002 May; 29(5):597-606. PubMed ID: 11976797
[TBL] [Abstract][Full Text] [Related]
10. Truncated glucagon-like peptide-1 (proglucagon 78-107 amide), an intestinal insulin-releasing peptide, has specific receptors on rat insulinoma cells (RIN 5AH).
Orskov C; Nielsen JH
FEBS Lett; 1988 Feb; 229(1):175-8. PubMed ID: 2831085
[TBL] [Abstract][Full Text] [Related]
11. Interaction of glucagon-like peptide-1(7-36)amide and somatostatin-14 in RINm5F cells and in the perfused rat pancreas.
Göke R; Fehmann HC; Richter G; Trautmann M; Göke B
Pancreas; 1989; 4(6):668-73. PubMed ID: 2573056
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone pretreatment of rat insulinoma cells decreases binding of glucagon-like peptide-1(7-36)amide.
Richter G; Göke R; Göke B; Arnold R
J Endocrinol; 1990 Sep; 126(3):445-50. PubMed ID: 2170555
[TBL] [Abstract][Full Text] [Related]
13. Characterization of receptors for glucagon-like peptide-1(7-36)amide on rat lung membranes.
Richter G; Göke R; Göke B; Arnold R
FEBS Lett; 1990 Jul; 267(1):78-80. PubMed ID: 2163902
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of glucagon-like peptide-1(7-36)amide: insulinotropic activities in perfused rat pancreases, and receptor binding and cyclic AMP production in RINm5F cells.
Watanabe Y; Kawai K; Ohashi S; Yokota C; Suzuki S; Yamashita K
J Endocrinol; 1994 Jan; 140(1):45-52. PubMed ID: 8138751
[TBL] [Abstract][Full Text] [Related]
15. Rat parietal cell receptors for GLP-1-(7-36) amide: northern blot, cross-linking, and radioligand binding.
Schmidtler J; Dehne K; Allescher HD; Schusdziarra V; Classen M; Holst JJ; Polack A; Schepp W
Am J Physiol; 1994 Sep; 267(3 Pt 1):G423-32. PubMed ID: 7943240
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the receptor for glucagon-like peptide-1(7-36)amide on plasma membranes from rat insulinoma-derived cells by covalent cross-linking.
Göke R; Cole T; Conlon JM
J Mol Endocrinol; 1989 Mar; 2(2):93-8. PubMed ID: 2550026
[TBL] [Abstract][Full Text] [Related]
17. Binding specificity and signal transduction of receptors for glucagon-like peptide-1(7-36)amide and gastric inhibitory polypeptide on RINm5F insulinoma cells.
Gallwitz B; Witt M; Fölsch UR; Creutzfeldt W; Schmidt WE
J Mol Endocrinol; 1993 Jun; 10(3):259-68. PubMed ID: 8396943
[TBL] [Abstract][Full Text] [Related]
18. Effects of glucagon-like peptide-1 (GLP-1) in RINm5F insulinoma cells. Stimulation of insulin secretion, insulin content, and insulin receptor binding.
Jehle PM; Jehle D; Fussgänger RD; Adler G
Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():31-6. PubMed ID: 8839251
[TBL] [Abstract][Full Text] [Related]
19. Structural characterization by affinity cross-linking of glucagon-like peptide-1(7-36)amide receptor in rat brain.
Calvo JC; Yusta B; Mora F; Blázquez E
J Neurochem; 1995 Jan; 64(1):299-306. PubMed ID: 7798926
[TBL] [Abstract][Full Text] [Related]
20. The processing of receptor-bound [125I-Tyr11]somatostatin by RINm5F insulinoma cells.
Sullivan SJ; Schonbrunn A
J Biol Chem; 1986 Mar; 261(8):3571-7. PubMed ID: 2869033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]